The most commonly reported side effects in clinical trials are gastrointestinal, including nausea, vomiting, diarrhoea, and constipation, which are typically most pronounced during the dose titration phase and tend to improve over time
Beyond medication, medical weight loss programs focus on sustainable lifestyle changes, including physical activity, meal planning, and nutrition counseling with registered dietitians
However, Dr Gary Deed, Chair of RACGP Specific Interests Diabetes, is worried that the flow-on effect may exacerbate semaglutide supply challenges that caused major disruption last year and are likely to continue until at least the end of 2023
The market in Canada is witnessing significant growth due to the growing emphasis on aging support and energy metabolism, with a large consumer base
Among patients who switched to a different GLP-1 RA medication, many of them switched from dulaglutide labeled for T2D (26.1%) or semaglutide labeled for T2D (21.0%)